GotchF.A.. Kinetik considerations of the dialysis prescription. Dialysis & Transplantation, 1986; 10: 553–4.
2.
LowrieE.G., LairdN.M.. The national cooperative dialysis study. Kidney Int, 1983; S13: 1–122.
3.
GotchF.A., SargentJ.A.. A mechanistic analysis of the national cooperative dialysis study. Kidney Int, 1985; 28: 526–34.
4.
SchindhelmK., FarrellP.C.. Patient-hemodialyzer intercations. Trans ASAIO, 1978; 24: 357–66.
5.
BrennanB.L., YasumuraS., LetteriJ.M., CohnH.. Total body electrolyte composition and distribution of body water in uremia. Kidney Int, 1980; 17: 364–71.
6.
GotchF.A.. Kinetic modeling in Hemodialysis. In: NissensonA., GentileD., FineR.A., eds. Clinical dialysis.Apple-ton, Century, Crofts Publ, Norwalk, 1989.
7.
AlloattiS., TorazzaM.C., Ne-bioloP.E., GaiterA.M., GabellaP., BosticardoG.M.. Is it rational to use Kt/V to calculate the treatment time for high efficiency dialysis?Int J Artif Organs, 1989; 12(S4): 141–4.
8.
AlloattiS., BosticardoG.M.. Il modello cinetico dell'urea far-macocinetica della terapia dialitica. In: CambiV. ed. Trattato italiano di dialisi.Wichtig Editore1989 (in stampa).
9.
TsangH.K., LeonhardE.F., Le-favourS., CortellS.. Urea dynamics during and immediately after dialysis. Trans ASAIO, 1985; 8: 251–60.
10.
CitterioA., Di FilippoS., PontiR.Limiti applicativi nella misurazione dell clearance in vivo. In: VercelloneA., PiccoliG. eds. Nefrologia '87. XXVIII Congr Soc It Nefrologia, Torino 1987, Acta Medica Edizioni e Congressi, Roma1987; 377–80.
11.
CasinoF., SaccoA., GaudianoY.Il problema della clearance del dializzatore nella cinetica dell'urea. Giorn It Ne-frol, 1986; 3: 51–6.
12.
SargentJ.A., GotchF.A.. The analysis of concentration dependence of uremic lesions in clinical studies. Kidney Int1975; 2(S): 35–44.
13.
GhezziP.M., DuttoA., GervasioR., BotellaJ.. Hemodiafil-tration with separate convection and diffusion: Paired Filtration-Dialysis. Contr Nephrol, Karger, Basel1989; 69: 141–61.
14.
LowrieE.G., TeehanB.P.. Principles of prescribing dialysis therapy: implementing recommandations from the national cooperative dialysis study. Kidney Int, 1983; 13(S): 113–22.
15.
KeshaviahP.R., HansonG.L., BerksethR.O., CollinsA.J.. A simplified approach to monitoring in vivo therapy prescription. Trans ASAIO, 1988; 34: 620–2.
16.
CalzavaraP., VianelloA., Da PortoA.Comparison between three mathematical models of Kt/V. Int J Artif Organs, 1988; 11: 107–10.
17.
JindalK.K., ManuelA., GoldsteinB.. Percent reduction in blood urea concentration during hemodialysis (PRU). Trans ASAIO, 1987; 33: 286–8.
18.
PedriniL.A., ZereikS., RasmyS.. Causes, kinetics and clinical implications of post-hemodia-lysis urea rebound. Kidney Int, 1988; 34: 817–24.
19.
GejyoF., YamadaT., OdaniS.. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Bio-phys Res Commun, 1985; 129: 701–6.
20.
GejyoF., BrancaccioD.. Beta2-microglobulin: a possible new uremic toxin?Int J Artif Organs, 1988; 11: 3–5.
21.
BrancaccioD., GallieniM., AnelliA., PadoveseP., SabbioniE., BerlinA.. Generation and removal of beta2-microglobu-lin by dialysis. In: GejyoF., BrancaccioD., BardinT. eds. Dialysis amyloidosis.Milano, Wichtig Eeditore1989; 131–40.
